World-class
market experts
guide you to
invest smarter
& trade wiser.

1,340 Experts | 29 Virtual Expos
5 Conferences | 55 Courses
33,214 Articles | 4,053 Videos

Conferences


Virtual Learning

Global maritime shipping sectors have performed exceptionally well in 2021 as investor attention returns to global recovery trends. Several segments of the global logistics industry are enjoying near-record profits and cash flows with the outlook improving further into 2022 and beyond. J Mintzmyer, a renowned global maritime shipping expert, will walk investors through the key segments of the industry and share insights about which areas and companies are best positioned both for ongoing recovery trades and also for potential long-term investments. Join for the latest global trade commentary as well as an educational seminar on a fascinating, but often overlooked, key segment of the global economy.
Artificial intelligence is changing the world in numerous industries. Find out in this session how AI is at the onset of disrupting civil and critical infrastructure like never before. American Infrastructure Group's proprietary technology algorithms can process data analytics in a matter of hours versus weeks or months. US Infrastructure spending will reach $396 Billion (Annually) by 2022 where the majority of processes are still done manually. This comes ahead of the potential $1+ Trillion spending bill from Washington.
Zhittya Genesis Medicine, Inc., is developing novel pharmaceuticals that have the potential to treat and reverse diseases that account for more than 50% of all adult deaths, worldwide. In FDA-authorized clinical trials these drugs have shown remarkable success in reversing severe coronary artery disease and healing chronic diabetic foot ulcers. New clinical trials are planned in the coming year to treat patients with Parkinson's disease, ALS (Lou Gehrig's disease), multiple sclerosis, chronic stroke, and Alzheimer's disease. A very attractive Pre-IPO investment is now being offered to suitable investors to help fund the upcoming IPO, which has a firm commitment from a highly regarded securities firm and will take place in 5-6 months.
All wealth comes from the land. Something grown, built, or mined. David Morgan will take you on a journey as to how and why mineral wealth is the next largest trend. As accredited investors, you have a unique opportunity to build legacy wealth for generations. You will learn how to diversify and Mr. Morgan will provide one company to you that is on the verge of changing the entire mining industry.
Austin, Texas continues to outperform the nation in jobs, capital, and technology advancement. Texas remains a national leader for commercial real estate. Multifamily apartments are a hard asset that experienced investors seek for positive investment returns. Join Presario Ventures' principal, Darin Davis, as he highlights the attraction and opportunities for Multifamily real estate in his hometown, Austin, Texas.
Join First National Realty Partners' managing principal and co-founder, Anthony Grosso, to discover how you can invest in daily-needs, grocery-anchored retail shopping centers. He will review FNRP's unique tenant-centric, value-added investment philosophy and show you how you can get involved in its most recent Kroger-anchored offering in one of the hottest markets in the country.
Texas is booming, and it is just getting started, which makes Texas a great place to invest in real estate. Learn how and why BV Capital invests in Texas real estate and what it can do for your portfolio. The company's projects include multifamily, student housing, industrial net lease, office, single-family lot development, and mixed-use projects. Rob Anderson will talk about each of these with active deals and case studies, and what unique benefits investing in each of these property types offer investors.
With the recent acquisition of GWPH by Jazz Pharmaceuticals, many investors are wondering who might follow in their footsteps. Skye Bioscience (SKYE) has the right set-up—and advantages—to not just follow GW's leadership but carve a new path. SKYE is working to solve the world's leading cause of irreversible blindness by applying advanced science to uniquely unlock the therapeutic potential of cannabinoids and create important new pharmaceutical medicines. The lead program targets glaucoma, a disease with no cure and the world's leading cause of irreversible blindness. Preclinical data has demonstrated that SKYE's lead molecule, THCVHS, provides superior lowering of intraocular pressure, a key cause of vision loss, compared to the top commercially marketed classes of drugs that represent 80% of a nearly $7 billion market opportunity. With key value driving milestone and catalyst on the horizon SKYE is poised for significant growth.

Virtual Expos




A 40-Year Passion and History

MoneyShow has a long history of creating successful investors and traders through timely investing and trading education, delivered by powerful experts who are best-selling authors, market analysts, portfolio managers, award-winning financial journalists, and newsletter editors. With MoneyShow’s interactive environment, our audience of over one million passionate investors and traders are offered a unique format of live, interactive exchange, which generates unparalleled experience for both the expert and the investor and trader.

With constant network expansion, we continue to create broader distribution of our expert commentary through virtual events, face-to-face forums, social media, and in-depth courses that educate and guide qualified investors and traders to outperform the market. Each session energizes, empowers, and educates everyone who participates. The opportunity for learning and profit within this highly charged atmosphere draws hundreds of thousands of enthusiasts, year after year.

View Courses
Live Now

Accredited Investors Virtual Expo

July 27 - 29, 2021